Literature DB >> 12163625

Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.

Christiane Franzius1, Stefan Bielack, Silke Flege, Joachim Sciuk, Heribert Jürgens, Otmar Schober.   

Abstract

UNLABELLED: The purpose of this retrospective analysis was to evaluate the prognostic significance of both initial glucose metabolism as measured by (18)F-FDG PET and osteoblastic activity as measured by (99m)Tc-methylene diphosphonate (MDP) bone scintigraphy in osteosarcoma.
METHODS: In 29 patients (18 male, 11 female; age range, 5-41 y) with primary osteosarcoma, (18)F-FDG uptake and (99m)Tc-MDP uptake were measured semiquantitatively (average and maximum tumor-to-nontumor ratios [T/NT(av) and T/NT(max), respectively]) using PET and bone scintigraphy at the time of diagnosis. After chemotherapy, the patients underwent surgery for their primary tumor, and the response was determined histologically. Cumulative overall survival and event-free survival were determined by clinical and imaging follow-up of 7-72 mo (median, 28 mo).
RESULTS: Clinical and imaging follow-up revealed that the disease relapsed or failed to achieve complete remission in 9 patients and that 6 patients died of the disease. Both overall and event-free survival were significantly better in patients with a low (18)F-FDG T/NT(max) (less than the median) than in patients with a high (18)F-FDG T/NT(max) (at least the median). The negative relationship of (18)F-FDG T/NT(av), (99m)Tc-MDP T/NT(max), and (99m)Tc-MDP T/NT(av) with overall and event-free survival did not reach a level of significance. (18)F-FDG uptake values correlated moderately and positively with (99m)Tc-MDP uptake values, but a level of significance was reached only between (18)F-FDG T/NT(max) and (99m)Tc-MDP T/NT(av).
CONCLUSION: The initial glucose metabolism of primary osteosarcoma as measured by (18)F-FDG PET using T/NT(max) provides prognostic information. High (18)F-FDG uptake correlates with poor outcome. Thus, (18)F-FDG uptake may be complementary to other well-known factors in judging the prognosis in osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163625

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

2.  Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  Ruoh-Fang Yen; Tony Hsiu-Hsi Chen; Lai-Lei Ting; Kai-Yuan Tzen; Mei-Hsiu Pan; Ruey-Long Hong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-18       Impact factor: 9.236

Review 3.  18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-06

Review 4.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

5.  How PET/MR Can Add Value For Children With Cancer.

Authors:  Heike Daldrup-Link
Journal:  Curr Radiol Rep       Date:  2017-02-21

6.  Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.

Authors:  Caitlin Hurley; M Beth McCarville; Barry L Shulkin; Shenghua Mao; Jianrong Wu; Fariba Navid; Najat C Daw; Alberto S Pappo; Michael W Bishop
Journal:  Pediatr Blood Cancer       Date:  2016-04-15       Impact factor: 3.167

Review 7.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

Authors:  Hervé Brisse; Liliane Ollivier; Véronique Edeline; Hélène Pacquement; Jean Michon; Christophe Glorion; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2004-04-22

8.  Colour Doppler ultrasound predicts chemotherapy response, but not survival in paediatric osteosarcoma.

Authors:  Jos A M Bramer; Feikje M Gubler; Mario Maas; Hans Bras; Jan de Kraker; Jan W van der Eijken; Gerard R Schaap
Journal:  Pediatr Radiol       Date:  2004-05-18

9.  Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis.

Authors:  Colleen M Costelloe; A Kevin Raymond; Nancy E Fitzgerald; Osama R Mawlawi; Rodolfo F Nunez; John E Madewell; Robyn K Harrell; Roland L Bassett; Edith M Marom
Journal:  Skeletal Radiol       Date:  2009-09-17       Impact factor: 2.199

Review 10.  PET-CT imaging in pediatric oncology.

Authors:  M Beth McCarville
Journal:  Cancer Imaging       Date:  2009-06-29       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.